Simultaneous densitometric determination of indomethacin and its degradation products, 4-chlorobenzoic acid and 5-methoxy-2-methyl-3-indoleacetic acid, in pharmaceutical preparations.
J Krzek, M Starek
Index: J. AOAC Int. 84(6) , 1703-7, (2001)
Full Text: HTML
Abstract
A densitometric method was developed for the identification and determination of indomethacin and its degradation products, 4-chlorobenzoic acid and 5-methoxy-2-methyl-3-indoleacetic acid, in pharmaceuticals. To separate these compounds, silica gel-coated thin-layer chromatography plates and the following mobile phase were used: 2-propanol-25% ammonia-water (8 + 1 + 1, v/v). UV densitometric measurements were made by comparing the absorption spectra and Rf values of appropriate standards with the pharmaceutical preparations examined. The conditions for separation were established and a low detection limit was obtained. Average recoveries were 100.69, 90.09, and 91.17% for indomethacin, 4-chlorobeznzoic acid, and 5-methoxy-2-methyl-3-indoleacetic acid, respectively.
Related Compounds
Related Articles:
1982-07-01
[J. Pharm. Sci. 71(7) , 828-30, (1982)]
2004-06-15
[J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 805(2) , 223-34, (2004)]
2004-08-01
[Eur. J. Neurosci. 20(3) , 671-83, (2004)]
1994-09-01
[Cell Growth Differ. 5(9) , 1005-14, (1994)]
[J. Chromatogr. A. 306 , 315-21, (1984)]